Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis
Go back to Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis| (NASDAQ: CALT) | Delayed: 40.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.00 | 52 Week High | $ | |||
| Open | $40.00 | 52 Week Low | $ | |||
| Day High | $40.00 | P/E | N/A | |||
| Day Low | $40.00 | EPS | $ | |||
| Volume | 1,789,544 | |||||
